Replies to post #242284 on Biotech Values

[ciotera]

And CYTK is up. It's nice to see the market react rationally to the news once in a while. Now if I could only figure out when it does that, I may even start making some money.

[DewDiligence]

LIAN +7% on phase-3 Mavacamten data:

https://www.globenewswire.com/news-release/2023/04/26/2655000/0/en/LianBio-Announces-Positive-Topline-Results-from-Phase-3-EXPLORER-CN-Trial-Evaluating-Mavacamten-in-Chinese-Patients.html

Curiously, BMY, which owns the rights to Camzyos/Mavacamten outside of Greater China, is down 3% today.